Announced Tue, 23 Jun · 19:26 IST
Corrigendum to EGM Notice for Preferential Issue of Warrants
Management Changes View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+4.0%1-day move
₹72.17
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————+4.0+6.1+8.2+10.4+12.6+17.1+37.1+42.5——
Up moveDown movePending
AI summary
Parmax Pharma issued a corrigendum to its June 8, 2026 EGM notice. Two corrections: (a) Ms. Sheetal Hiren Doshi's category in the warrant allottees table changed from Promoter to Promoter Group, and (b) hyperlink for the Practicing Company Secretary's certificate fixed. The July 2 EGM will consider a preferential issue of 21.45 lakh warrants for about Rs 7.83 crore to 13 allottees, who will trigger an open offer and be reclassified as Promoters or Promoter Group members.
Likely market impact
Minor admin correction to EGM notice; substance of preferential issue and open offer trigger unchanged. No material impact on shareholders.